Literature DB >> 10881172

Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity.

M Yan1, S A Marsters, I S Grewal, H Wang, A Ashkenazi, V M Dixit.   

Abstract

B lymphocyte stimulator (BLyS) is a member of the tumor necrosis factor (TNF) superfamily. BLyS stimulates proliferation of, and immunoglobulin production by, B cells. However, the relative importance of BLyS in physiological B cell activation is unclear. We identified a B cell receptor for BLyS through expression cloning as TACI, an orphan TNF receptor homologue of unknown function. Binding of BLyS to TACI activated signaling by nuclear factor-kappa B (NF-kappa B). In vitro soluble TACI-Fc fusion protein blocked BLyS-induced NF-kappa B activation in B lymphoma cells and IgM production in peripheral blood B cells. In vivo treatment of immunized mice with TACI-Fc inhibited production of antigen-specific IgM and IgGI antibodies and abolished splenic germinal center (GC) formation. Thus, BLyS activity must play a critical role in the humoral immune response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10881172     DOI: 10.1038/76889

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  69 in total

1.  The buzz about BAFF.

Authors:  David L Vaux
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

Review 2.  Maintenance and loss of self-tolerance in B cells.

Authors:  A Iglesias
Journal:  Springer Semin Immunopathol       Date:  2001-12

3.  T cell control of the gut IgA response against commensal bacteria.

Authors:  N A Bos; H Q Jiang; J J Cebra
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

4.  B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses.

Authors:  S Xu; K P Lam
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

5.  DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL.

Authors:  Mikhail B Litinskiy; Bernardetta Nardelli; David M Hilbert; Bing He; Andras Schaffer; Paolo Casali; Andrea Cerutti
Journal:  Nat Immunol       Date:  2002-08-05       Impact factor: 25.606

Review 6.  Homeostatic control of B lymphocyte subsets.

Authors:  Jenni E Crowley; Jean L Scholz; William J Quinn; Jason E Stadanlick; John F Treml; Laura S Treml; Yi Hao; Radhika Goenka; Patrick J O'Neill; Andrew H Matthews; Ronald F Parsons; Michael P Cancro
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

7.  B-cell activating factor-receptor specific activation of tumor necrosis factor receptor associated factor 6 and the phosphatidyl inositol 3-kinase pathway in lymphoma B cells.

Authors:  Frank Secreto; Michelle Manske; Tammy Price-Troska; Steven Ziesmer; Lucy S Hodge; Stephen M Ansell; James R Cerhan; Anne J Novak
Journal:  Leuk Lymphoma       Date:  2014-02-24

8.  Unexpected development of autoimmunity in BAFF-R-mutant MRL-lpr mice.

Authors:  Zhong L Ju; Gui Y Shi; Jin X Zuo; Jing W Zhang
Journal:  Immunology       Date:  2006-10-31       Impact factor: 7.397

Review 9.  B lymphocyte stimulator protein levels in systemic lupus erythematosus and other diseases.

Authors:  William Stohl
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

10.  Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes.

Authors:  Li Zhang; Lin Radigan; Ulrich Salzer; Timothy W Behrens; Bodo Grimbacher; George Diaz; James Bussel; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol       Date:  2007-11       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.